Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: A retrospective review at a UK tertiary centre

ConclusionsWith pulsed echinocandin therapy, azole ‐intolerant or pan‐resistant CPA patients have similar mortality rates to azole‐naïve CPA patients. Pulsed echinocandin therapy may present a strategy to stabilize CPA in patients with pan resistance or intolerance to, azole therapy.

Source: The Clinical Respiratory Journal - March 7, 2020 Category: Respiratory Medicine Authors: William Osborne, Michelle Fernandes, Sophie Brooks, Emily Grist, Charlie Sayer, David M. Hansell, Robert Wilson, Anand Shah, Michael R. Loebinger Tags: ORIGINAL ARTICLE Source Type: research